![15 Posts From ASCO24 Day 3 You Should Not Miss!](https://oncodaily.com/pub/uploads/2024/06/download-2-1280x635.png)
15 Posts From ASCO24 Day 3 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May 31st to June 4th 2024.
Our team at OncoDaily selected the most important posts from Day 3 of ASCO24 that you should not miss.
Investing in the next generation of oncologists is crucial for the future of cancer research. At ASCO24, let’s continue to support and mentor young talents who will drive innovation and breakthroughs in oncology. Together, we can achieve more!
We are overwhelmed with support and love and more importantly, excitement about working together to take our recommendations forward from The Lancet Commission on Women, Power, and Cancer!
Special thanks to the American Society of Clinical Oncology (ASCO), Dr. Julie Gralow whose unwavering support and wise counsel helped move this forward – and ASCO President Dr. Lynn Schucter who came to our African launch in Senegal and invited us to contribute to a session at this year’s ASCO event in Chicago.
Women lifting up women – this is the way it’s done!
Read the report. Join the movement.
Not every day that you get to celebrate a years-long survival advantage in the treatment of small cell lung cancer!
Mind-blowing to see the median overall survival for limited stage SCLC approach the oncologically conventional 5-year milestone at ASCO24.
No difference seen in ablation surgery for small sized liver metastases from colorectal cancer. Even though it’s reserved as a backup to surgery, trial had to be stopped half way since it’s as good as (if now lower morbidity). Collision trial at ASCO24.